SoylentNews

Freeman [soylentnews.org] writes:

https://arstechnica.com/health/2023/10/covid-antiviral-paxlovid-to-see-price-increase-following-400-vaccine-hike/ [arstechnica.com]

After raising the price of COVID-19 vaccines more than fourfold this year, Pfizer CEO Albert Bourla told investors Monday [pfizer.com] that the company will also likely hike the price of its lifesaving COVID-19 antiviral treatment, Paxlovid, raising further concern about access and health care costs.

The price of the drug is already $530 for a treatment course.
[...]
In a company investor call Monday, Bourla said only that the "pandemic price" of $530 is likely to be "lesser" than the commercial price and that negotiations are beginning.

One financial analyst who follows the company, Evercore ISI’s Umer Raffat, told CNN [cnn.com] that the price could go up roughly three- to fivefold, to as much as $2,500 per course.

Original Submission